Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity

Although immunotherapies have achieved remarkable salutary effects among subgroups of advanced cancers, most patients do not respond. We comprehensively evaluated biomarkers associated with the “cancer-immunity cycle” in the pan-cancer setting in order to understand the immune landscape of metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Shumei, Okamura, Ryosuke, Kumaki, Yuichi, Ikeda, Sadakatsu, Nikanjam, Mina, Eskander, Ramez, Goodman, Aaron, Lee, Suzanna, Glenn, Sean T., Dressman, Devin, Papanicolau-Sengos, Antonios, Lenzo, Felicia L., Morrison, Carl, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028323/
https://www.ncbi.nlm.nih.gov/pubmed/32117584
http://dx.doi.org/10.1080/2162402X.2019.1708065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028323/
https://www.ncbi.nlm.nih.gov/pubmed/32117584
http://dx.doi.org/10.1080/2162402X.2019.1708065

Ejemplares similares